School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
North Bristol NHS Trust, Bristol, United Kingdom.
Elife. 2020 Dec 17;9:e63430. doi: 10.7554/eLife.63430.
Here, we describe the case of a COVID-19 patient who developed recurring ventilator-associated pneumonia caused by that acquired increasing levels of antimicrobial resistance (AMR) in response to treatment. Metagenomic analysis revealed the AMR genotype, while immunological analysis revealed massive and escalating levels of T-cell activation. These were both SARS-CoV-2 and specific, and bystander activated, which may have contributed to this patient's persistent symptoms and radiological changes.
在这里,我们描述了一例 COVID-19 患者的情况,该患者因治疗而导致获得性抗菌药物耐药性(AMR)不断增加,从而反复发生呼吸机相关性肺炎。宏基因组分析揭示了 AMR 基因型,而免疫分析揭示了大量和不断升级的 T 细胞激活。这些都是 SARS-CoV-2 和 的特异性和旁观者激活的,这可能导致了该患者持续的症状和影像学改变。